The original short thesis was predicated on a post-earnings pullback due to valuation concerns, but the magnitude of the beat and upward guidance revision has reinforced the growth story. Government tailwinds from the Pentagon's 'Maven' program and accelerating U.S. commercial adoption provide durable revenue visibility. Despite the counter-rally, the stock remains extended on valuation, and the technical structure still favors mean reversion toward $130.
The short should still be held because the market is continuing to treat PLTR's excellent quarter as insufficient relative to its extreme valuation, which is exactly the mechanism behind the original thesis. Technically, price is still below the 4H and daily SMA20/50 cluster and has not reclaimed the nearby $135.38-$136.97 resistance zone, leaving the path to the $130 target open within the remaining horizon.
Continued AI infrastructure spending and recurring revenue growth validate premium, leading to price holding above support and resuming trend toward target over the remaining 2-4 weeks
No model argued for EXIT.
The short should still be held because the market is continuing to treat PLTR's excellent quarter as insufficient relative to its extreme valuation, which is exactly the mechanism behind the original thesis. Technically, price is still below the 4H and daily SMA20/50 cluster and has not reclaimed the nearby $135.38-$136.97 resistance zone, leaving the path to the $130 target open within the remaining horizon.
The short should still be held because the market is continuing to treat PLTR's excellent quarter as insufficient relative to its extreme valuation, which is exactly the mechanism behind the original thesis. Technically, price is still below the 4H and daily SMA20/50 cluster and has not reclaimed the nearby $135.38-$136.97 resistance zone, leaving the path to the $130 target open within the remaining horizon.
▼ Click to expandThe trade should be closed if the current dip has already exhausted the post-earnings valuation reset and buyers reclaim the $135-$137 resistance area with follow-through. A move back above that zone would weaken the bearish structure, increase the odds of a squeeze toward the moving averages near $140+, and materially reduce the probability of reaching $130 before time decay works against the trade.
▼ Click to expandThe original short thesis was predicated on a post-earnings pullback due to valuation concerns, but the magnitude of the beat and upward guidance revision has reinforced the growth story. Government tailwinds from the Pentagon's 'Maven' program and accelerating U.S. commercial adoption provide durable revenue visibility. Despite the counter-rally, the stock remains extended on valuation, and the technical structure still favors mean reversion toward $130.
The original short thesis was predicated on a post-earnings pullback due to valuation concerns, but the magnitude of the beat and upward guidance revision has reinforced the growth story. Government tailwinds from the Pentagon's 'Maven' program and accelerating U.S. commercial adoption provide durable revenue visibility. Despite the counter-rally, the stock remains extended on valuation, and the technical structure still favors mean reversion toward $130.
▼ Click to expandPLTR has already declined 4.07% since entry and is approaching the target, reducing reward potential. The earnings beat and raised guidance have shifted sentiment positively, with multiple analysts upgrading the stock. The 4h RSI is rising and MACD histogram is improving, suggesting momentum may be building to retest resistance. Holding a short into strengthening momentum increases risk of a squeeze.
▼ Click to expandContinued AI infrastructure spending and recurring revenue growth validate premium, leading to price holding above support and resuming trend toward target over the remaining 2-4 weeks
Continued AI infrastructure spending and recurring revenue growth validate premium, leading to price holding above support and resuming trend toward target over the remaining 2-4 weeks
▼ Click to expandIntraday discovery triggered reanalysis on PLTR. Verdict: HOLD (0/3 EXIT). Conviction: 51.